Eli Lilly Case Over Weight Loss Drugs Kept Mostly Intact

By Adam Lidgett · April 22, 2026, 7:24 PM EDT

A California federal court has refused to throw out a lawsuit from Eli Lilly against a telehealth company and related entities over the compounding of its popular weight loss drugs Mounjaro...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Decision

Case Information

Case Title

Eli Lilly and Company v. Mochi Health Corp. et al

Case Number

Court

California Northern

Nature of Suit

Other Statutory Actions

Date Filed

April 23, 2025

Recent Articles By Adam

April 22, 2026
Oura Hit With New Patent Suit Over Fitness Wearables
April 21, 2026
Congress Rallies More For Bills On Copyrights Than Patents
April 15, 2026
Fertility Biz Progyny Hit With TM Suit In Pennsylvania
April 09, 2026
Abiomed Can't Escape Blood Pump Patent Case
April 02, 2026
Alexion Beats Trade Secret Claims In Amyndas Suit
March 27, 2026
Eli Lilly Keeps Most Of Weight Loss Drug Copy Suit Alive
March 24, 2026
Sarepta Urges Full Fed. Circ. To Wipe Out Gene Therapy IP
March 24, 2026
ITC Says Hydrafacial Patent Infringed, But Won't Ban Imports
March 12, 2026
US Chamber Report Warns Of Risks To IP Protection
March 04, 2026
Care Management Co. Accused Of Swiping Software Platform